- Home
- EM vs ENGN Comparison
EM vs ENGN Comparison
Compare EM & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EM | ENGN |
|---|---|---|
| Founded | 2017 | 1999 |
| Country | China | Canada |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 339.8M | 379.3M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | EM | ENGN |
|---|---|---|
| Price | $1.19 | $8.57 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 7 |
| Target Price | $1.25 | ★ $22.71 |
| AVG Volume (30 Days) | ★ 715.2K | 331.3K |
| Earning Date | 11-26-2025 | 12-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $259,541,587.00 | N/A |
| Revenue This Year | $3.30 | N/A |
| Revenue Next Year | $5.26 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.68 | $2.65 |
| 52 Week High | $1.46 | $11.14 |
Technical Indicators
Market Signals| Indicator | EM | ENGN |
|---|---|---|
| Relative Strength Index (RSI) | 23.06 | 56.36 |
| Support Level | $1.33 | $7.57 |
| Resistance Level | $1.36 | $8.47 |
| Average True Range (ATR) | 0.05 | 0.64 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 10.00 | 63.69 |
Price Performance
Historical ComparisonAbout EM Smart Share Global Limited
Smart Share Global Ltd is a consumer tech company providing mobile device charging services through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Geographically, the company generates revenue from the PRC. The company has two segments, the mobile device charging segment and the PV business segment. The company generates the majority of its revenue from the mobile device charging segment.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.